Research

AOD-9604 and HGH Fragment 176-191 are both derived from human growth hormone and studied for fat metabolism. Here is what the research actually shows when you compare them head to head.

Complex Regional Pain Syndrome is one of the most difficult-to-treat pain conditions. Research into peptides like BPC-157 and TB-500 explores their potential roles in reducing neuroinflammation and supporting tissue repair.

Post-herpetic neuralgia is one of the most persistent nerve pain conditions after shingles. Research peptides like BPC-157 are being studied for their effects on nerve repair and pain modulation.

Epithalon is studied for telomere lengthening and anti-aging effects. Research participants commonly report improved sleep quality, increased energy, and enhanced well-being. This FAQ explores what the science and participant accounts say about the Epithalon experience.

Retatrutide (triple GIP/GLP-1/Glucagon agonist) and Mazdutide (dual GLP-1/Glucagon agonist) are the leading next-generation metabolic peptides. Retatrutide produced up to 24.2% weight loss in Phase 2 — the highest ever seen in obesity pharmacology.

Diabetic peripheral neuropathy affects up to 50% of diabetes patients and has no disease-modifying treatments. Research into BPC-157 and SS-31 explores vascular, anti-inflammatory, and mitochondrial protection mechanisms relevant to nerve damage in diabetes.

Peripheral neuropathy — nerve damage outside the brain and spinal cord — is often difficult to reverse. BPC-157 and Cerebrolysin show nerve regeneration and neuroprotective properties in preclinical models, making them active subjects of nerve repair research.